Skip to main content
. 2019 Jan 25;14(1):e0211012. doi: 10.1371/journal.pone.0211012

Fig 7. Comparison of calculated human organ dose from FDG-labeled erythrocytes with intravenous (IV) FDG.

Fig 7

Organ dose estimates from FDG-labeled erythrocytes were calculated under conditions of 100% in vivo FDG retention and decay (FDG RBCs Ideal), and after 25% FDG excretion (FDG RBCs 25% free). In addition, organ dose estimates for intravenous FDG injection (FDG IV Ideal) were also calculated for comparison purposes.